Access Statistics for Anirban Basu

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures 0 0 1 39 0 3 14 40
Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care 0 0 1 44 2 5 14 144
Estimating Lifetime or Episode-of-illness Costs 0 0 1 100 0 3 15 259
Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables 0 0 0 51 2 2 8 147
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 1 1 1 11 1 1 13 80
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 35 1 1 14 123
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 0 287 1 3 7 851
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 1 41 0 1 5 145
Impact of Rural and Urban Hospital Closures on Inpatient Mortality 5 17 72 72 11 36 61 62
Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State 0 0 1 15 1 1 5 33
Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting 0 0 2 51 0 2 12 47
Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion 0 0 0 50 2 3 13 26
Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment 0 0 1 7 3 9 17 37
The Impact of Comparative Effectiveness Research on Health and Health Care Spending 0 0 1 57 0 1 7 221
The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices 0 0 2 67 3 4 24 69
The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health 0 1 4 39 0 1 6 86
The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures 0 0 0 41 1 1 7 154
Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures 0 0 0 53 0 1 10 204
Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients 1 1 3 471 3 3 23 1,293
Use of propensity scores in non-linear response models: The case for health care expenditures 0 0 0 144 0 2 14 475
Welfare Implications of Learning Through Solicitation versus Diversification in Health Care 0 0 0 35 1 1 6 44
Total Working Papers 7 20 91 1,710 32 84 295 4,540

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS? 0 0 0 0 0 0 4 15
Comparing alternative models: log vs Cox proportional hazard? 1 2 4 138 2 4 11 544
Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients? 0 0 0 0 2 3 5 304
ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS 0 0 0 4 0 0 2 27
Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care 0 0 0 27 0 3 18 190
Erratum: Estimating lifetime or episode‐of‐illness costs under censoring 0 0 0 15 0 1 4 43
Estimating lifetime or episode‐of‐illness costs under censoring 0 1 2 14 0 2 6 65
Extended generalized linear models: Simultaneous estimation of flexible link and variance functions 0 0 3 134 0 0 8 390
Generalized modeling approaches to risk adjustment of skewed outcomes data 0 0 1 136 0 2 9 333
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 1 2 3 20
HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE 0 3 12 81 0 8 40 205
Implications of spillover effects within the family for medical cost-effectiveness analysis 0 0 4 69 1 2 15 172
Measuring the Value of Pharmaceuticals in the US Health System 0 0 0 4 0 0 2 12
Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables 0 0 1 31 0 1 4 121
Personalized Medicine in the Context of Comparative Effectiveness Research 0 1 4 13 2 5 29 98
Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials 0 0 0 5 1 1 6 47
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 1 1 1 1 5 15
Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity 0 1 2 49 2 4 6 202
The impact of comparative effectiveness research on health and health care spending 0 0 0 32 0 2 10 252
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling 1 1 11 876 4 8 62 2,513
Welfare implications of learning through solicitation versus diversification in health care 0 0 0 2 0 1 7 27
Total Journal Articles 2 9 45 1,633 16 50 256 5,595

Software Item File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
IVCHECK: Stata module to choose between OLS and contaminated IV 0 0 1 23 4 8 30 175
Total Software Items 0 0 1 23 4 8 30 175

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Statistics updated 2020-09-04